Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.
about
Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimenCharacterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in MacaquesVaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicityPolyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques.Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectorsPersistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.Non-human primate models for AIDS vaccine research.Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5)Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon.Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.Simian immunodeficiency virus DNA vaccine trial in macaques.Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques.Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccinesAn epitope in the V1 domain of the simian immunodeficiency virus (SIV) gp120 protein is recognized by CD8+ cytotoxic T lymphocytes from an SIV-infected rhesus macaqueVaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates.IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenicIncreased Virus Replication and Cytotoxicity of Non-pathogenic Simian Human Immuno Deficiency Viruses-NM-3rN After Serial Passage in a Monkey-Derived Cell Line.Identification of highly attenuated mutants of simian immunodeficiency virus.Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.Where are we now with vaccines against AIDS?
P2860
Q33639684-15EE5F7B-01EF-4F37-97BD-C58D843261A6Q33783464-092E9BFD-5AE3-4845-936E-71320674B4D2Q33810277-608EB7EC-A567-4F83-B922-1F214AB6CCF1Q33819493-FCBB5204-FE79-4C24-A3C1-4CD497C829C0Q33834391-9C851B80-2CE5-4266-BE17-12BEF79DA68EQ33850605-D952A8FF-FD31-4B88-8CA2-2F69817055B3Q33852720-5C86C244-157F-48FB-8E66-DCDFBC1CCEAEQ34060230-E5B3B594-7741-4769-9254-A66F5CDEF0CAQ34228507-51B413CD-D31C-4F23-9E10-0382D5B70D78Q34715769-CF104EEF-A5C1-458B-82B6-1561EFEF0E2EQ35848231-5B2DA91E-53DF-4346-A47E-8275355283EEQ35854152-42A9B4C1-A6E4-4D29-9AEA-352C0BDF35DFQ35858637-729F49A9-7FEA-4D16-BE6C-44F83A1AC625Q35861490-1BE6BCF5-55C5-4DCE-85EE-F4FA220D4E5CQ35861970-7B724D25-A022-49A7-A359-BBF572A8F006Q35876182-4FB21787-B5C9-450F-863B-146E14AC3530Q35897786-F1E59A88-0D65-4A8D-B8DD-464936C925F7Q36009232-F59000DD-6973-41D7-996C-502679EBF41CQ36630114-28EAE6ED-162D-4BF5-BF2F-F36C0354C840Q36632889-452DDFC7-8746-45D4-9633-845BBD70A664Q36636293-31B6FC38-5FBE-49F1-A114-640C836B4BF6Q36924415-14E60077-C08D-4352-A2B3-E4A29580DC7AQ37617613-E525F0EB-AE30-451A-8F92-391493DE4385Q39157862-641CDAEE-5ED1-484E-AB5B-35776DA1C399Q39642374-88F7D0DD-77BD-404E-BC97-7AB6652BCB6AQ39874667-71562E4E-77BE-4170-85A1-53928EB1E626Q43154059-64CA6D95-4B06-4F86-96D1-4411B814FE18
P2860
Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Immune response of rhesus maca ...... tect from challenge infection.
@ast
Immune response of rhesus maca ...... tect from challenge infection.
@en
type
label
Immune response of rhesus maca ...... tect from challenge infection.
@ast
Immune response of rhesus maca ...... tect from challenge infection.
@en
prefLabel
Immune response of rhesus maca ...... tect from challenge infection.
@ast
Immune response of rhesus maca ...... tect from challenge infection.
@en
P2093
P2860
P1433
P1476
Immune response of rhesus maca ...... otect from challenge infection
@en
P2093
L D Giavedoni
M B Gardner
M L Marthas
N L Haigwood
V Planelles
P2860
P304
P407
P577
1993-01-01T00:00:00Z